Cargando…

Design and Characterization of an “All-in-One” Lentiviral Vector System Combining Constitutive Anti-G(D2) CAR Expression and Inducible Cytokines

Genetically modified T cells expressing chimeric antigen receptors (CARs) so far have mostly failed in the treatment of solid tumors owing to a number of limitations, including an immunosuppressive tumor microenvironment and insufficient CAR T cell activation and persistence. Next-generation approac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zimmermann, Katharina, Kuehle, Johannes, Dragon, Anna Christina, Galla, Melanie, Kloth, Christina, Rudek, Loreen Sophie, Sandalcioglu, I. Erol, Neyazi, Belal, Moritz, Thomas, Meyer, Johann, Rossig, Claudia, Altvater, Bianca, Eiz-Vesper, Britta, Morgan, Michael Alexander, Abken, Hinrich, Schambach, Axel
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072617/ https://www.ncbi.nlm.nih.gov/pubmed/32041222 http://dx.doi.org/10.3390/cancers12020375

Ejemplares similares

Generation of an NFκB-Driven Alpharetroviral “All-in-One” Vector Construct as a Potent Tool for CAR NK Cell Therapy
por: Rudek, Loreen Sophie, et al.
Publicado: (2021)

GMP-Compliant Manufacturing of TRUCKs: CAR T Cells targeting GD(2) and Releasing Inducible IL-18
por: Glienke, Wolfgang, et al.
Publicado: (2022)

CAR-T cells and TRUCKs that recognize an EBNA-3C-derived epitope presented on HLA-B*35 control Epstein-Barr virus-associated lymphoproliferation
por: Dragon, Anna Christina, et al.
Publicado: (2020)

Ex Vivo Generation of CAR Macrophages from Hematopoietic Stem and Progenitor Cells for Use in Cancer Therapy
por: Paasch, Daniela, et al.
Publicado: (2022)

CAR T cells as micropharmacies against solid cancers: Combining effector T-cell mediated cell death with vascular targeting in a one-step engineering process
por: Altvater, Bianca, et al.
Publicado: (2023)

First in vivo visualization of the human subarachnoid space and brain cortex via optical coherence tomography
por: Hartmann, Karl, et al.
Publicado: (2019)

Theranostic applications of optical coherence tomography in neurosurgery?
por: Hartmann, Karl, et al.
Publicado: (2021)

CAR T Cells: A Snapshot on the Growing Options to Design a CAR
por: Holzinger, Astrid, et al.
Publicado: (2019)

CAR T cell therapy becomes CHIC: “cytokine help intensified CAR” T cells
por: Thomas, Simone, et al.
Publicado: (2023)

Carbohydrate Targets for CAR T Cells in Solid Childhood Cancers
por: Rossig, Claudia, et al.
Publicado: (2018)

Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells
por: Geis, Franziska K., et al.
Publicado: (2017)

Enhancement of Antiviral T-Cell Responses by Vitamin C Suggests New Strategies to Improve Manufacturing of Virus-Specific T Cells for Adoptive Immunotherapy
por: Laubert, Miriam, et al.
Publicado: (2022)

Is the central nervous system enclosed by a mesothel?
por: Hartmann, Karl, et al.
Publicado: (2023)

Correction to: Potent and reversible lentiviral vector restriction in murine induced pluripotent stem cells
por: Geis, Franziska K., et al.
Publicado: (2017)

VR-based training of craniotomy for intracranial aneurysm surgery
por: Allgaier, Mareen, et al.
Publicado: (2021)

CAR's made it to the pancreas
por: Chmielewski, Markus, et al.
Publicado: (2012)

CAR-Ts redirected against the Thomsen-Friedenreich antigen CD176 mediate specific elimination of malignant cells from leukemia and solid tumors
por: Dragon, Anna Christina, et al.
Publicado: (2023)

Overcoming Heterogeneity of Antigen Expression for Effective CAR T Cell Targeting of Cancers
por: Kailayangiri, Sareetha, et al.
Publicado: (2020)

Combining visual analytics and case-based reasoning for rupture risk assessment of intracranial aneurysms
por: Spitz, Lena, et al.
Publicado: (2020)

Definition and extraction of 2D shape indices of intracranial aneurysm necks for rupture risk assessment
por: Mittenentzwei, Sarah, et al.
Publicado: (2021)

Extravascular optical coherence tomography of cerebral vessel walls in vivo
por: Hartmann, Karl, et al.
Publicado: (2023)

Do Treg Speed Up with CARs? Chimeric Antigen Receptor Treg Engineered to Induce Transplant Tolerance
por: Kaljanac, Marcell, et al.
Publicado: (2022)

PSMA-Directed CAR T Cells Combined with Low-Dose Docetaxel Treatment Induce Tumor Regression in a Prostate Cancer Xenograft Model
por: Alzubi, Jamal, et al.
Publicado: (2020)

FimH-based display of functional eukaryotic proteins on bacteria surfaces
por: Chmielewski, Markus, et al.
Publicado: (2019)

VICTORIA: VIrtual neck Curve and True Ostium Reconstruction of Intracranial Aneurysms
por: Berg, Philipp, et al.
Publicado: (2021)

Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry
por: Eiz-Vesper, Britta, et al.
Publicado: (2013)

Most Do, but Some Do Not: CD4(+)CD25(−) T Cells, but Not CD4(+)CD25(+) Treg Cells, Are Cytolytic When Redirected by a Chimeric Antigen Receptor (CAR)
por: Hombach, Andreas A., et al.
Publicado: (2017)

Robust Identification of Suitable T-Cell Subsets for Personalized CMV-Specific T-Cell Immunotherapy Using CD45RA and CD62L Microbeads
por: Mangare, Caroline, et al.
Publicado: (2019)

IRF4 downregulation improves sensitivity and endurance of CAR T cell functional capacities
por: Harrer, Dennis Christoph, et al.
Publicado: (2023)

Selective Effects of mTOR Inhibitor Sirolimus on Naïve and CMV-Specific T Cells Extending Its Applicable Range Beyond Immunosuppression
por: Bak, Szilvia, et al.
Publicado: (2018)

Nanobody Based Dual Specific CARs
por: De Munter, Stijn, et al.
Publicado: (2018)

Anti-CD19 CARs displayed at the surface of lentiviral vector particles promote transduction of target-expressing cells
por: Cordes, Nicole, et al.
Publicado: (2021)

Rupture risk assessment for multiple intracranial aneurysms: why there is no need for dozens of clinical, morphological and hemodynamic parameters
por: Neyazi, Belal, et al.
Publicado: (2020)

Physiological lentiviral vectors for the generation of improved CAR-T cells
por: Tristán-Manzano, María, et al.
Publicado: (2022)

Physiological lentiviral vectors for the generation of improved CAR-T cells
por: Tristán-Manzano, María, et al.
Publicado: (2022)

Non-integrating gamma-retroviral vectors as a versatile tool for transient zinc-finger nuclease delivery
por: Bobis-Wozowicz, Sylwia, et al.
Publicado: (2014)

CAR Triggered Release of Type-1 Interferon Limits CAR T-Cell Activities by an Artificial Negative Autocrine Loop
por: Harrer, Dennis Christoph, et al.
Publicado: (2022)

A Small Number of HER2 Redirected CAR T Cells Significantly Improves Immune Response of Adoptively Transferred Mouse Lymphocytes against Human Breast Cancer Xenografts
por: Tóth, Gábor, et al.
Publicado: (2020)

S79. CAR strategies in solid tumours
por: Rossig, C
Publicado: (2014)

IL7-IL12 Engineered Mesenchymal Stem Cells (MSCs) Improve A CAR T Cell Attack Against Colorectal Cancer Cells
por: Hombach, Andreas A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2psmjd9gfnabt2u3fg4ctu28tn